The Addition of Neoadjuvant Pertuzumab for the Treatment of Her2+ Breast Cancer: a Cost Estimate with Real-World Data

AuthID
P-00V-DVY
13
Author(s)
Borges, A
·
Pereira, F
·
Redondo, P
·
Antunes, L
·
Vieira, C
·
Antunes, P
·
Bento, MJ
·
Sousa, S
·
de Sousa, JA
·
Pereira, DS
·
Borges, M
Tipo de Documento
Article
Year published
2021
Publicado
in Health Economics Review, ISSN: 2191-1991
Volume: 11, Número: 1
Indexing
Publication Identifiers
SCOPUS: 2-s2.0-85114711259
Source Identifiers
ISSN: 2191-1991
Export Publication Metadata
Info
At this moment we don't have any links to full text documens.